This trial will test whether undiluted microplegia reduces transfusion rates in patients after planned heart surgery, as compared to standard 4:1 cardioplegia.
2 Primary · 0 Secondary · Reporting Duration: 30 days
Active Control
314 Total Participants · 2 Treatment Groups
Primary Treatment: Microplegia · No Placebo Group · Phase 4
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: